While macrophages of active TB patients who had preexisting DM produced less GM-CSF compared to healthy controls, our data indicate that metabolic dysregulation is likely responsible for the reduced level of GM-CSF (Figures 6E–G). The gene discussed is CSF2; the disease is diabetes mellitus.